Free shipping on orders over $150
Ipamorelin 10mg research vial

peptides

Ipamorelin 10mg

Ipamorelin is a pentapeptide GHSR-1a agonist prized in research for producing clean, selective GH pulses without meaningful cortisol, prolactin, or appetite elevation.

Research-observed benefits

  • Selective GH pulse
  • No cortisol/prolactin spike
  • Sleep-architecture research
  • Recovery support

Findings reported in in-vitro / preclinical research literature. Not therapeutic claims.

CAS Number

Purity

99%+

Molecular Formula

Stock

120 units

Order type

Purchase option

Quantity

1

Total

$40

For in-vitro research only. Not for human consumption, diagnostic, or therapeutic use. Storage at -20°C recommended for lyophilized peptides.

Ipamorelin 10mg — Full Research Breakdown

Tailored information for researchers. All content is for in-vitro / preclinical research context only — not medical advice.

Mechanism of Action

Pentapeptide GHSR-1a (ghrelin receptor) agonist. Triggers a discrete GH pulse from pituitary somatotrophs with high receptor selectivity.

How It Helps

Produces GH release comparable to stronger secretagogues but without the cortisol, prolactin, or hunger elevation seen with GHRP-6 and hexarelin — the cleanest GH tool in secretagogue research.

Half-Life

~2 hours; GH pulse resolves within roughly 3 hours

Onset of Effects

Sleep-quality and recovery markers commonly shift within 2–4 weeks.

Storage

Lyophilized: –20°C. Reconstituted: 2–8°C, 30 days.

Stacks Well With

  • CJC-1295 (amplified GH pulse)
  • Tesamorelin (comparator)
  • BPC-157 (repair)

Research-Observed Side Effects

  • Injection-site reaction
  • Transient head-rush or flushing
  • Mild water retention

Translational Cautions

  • Active malignancy in human translation
  • Pituitary pathology

Research Highlights

  • Raabe et al.: selective GH release without ACTH/cortisol elevation.
  • Synergistic amplitude when combined with a GHRH analog such as CJC-1295.
  • Consistently improves slow-wave sleep metrics in research cohorts.

Researcher FAQ